Angiotensin converting enzyme inhibitor or angiotensin receptor blocker use among hypertensive US adults with albuminuria

Since 2003, US hypertension guidelines have recommended angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) as first-line antihypertensive therapy in the presence of albuminuria (urine albumin/creatinine ratio ≥300 mg/g). To examine national trends in guideline-con...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hypertension
Autores principales: Chu, Chi D., Powe, Neil R., McCulloch, Charles E., Banerjee, Tanushree, Crews, Deidra C., Saran, Rajiv, Bragg-Gresham, Jennifer, Morgenstern, Hal, Pavkov, Meda E., Saydah, Sharon H., Tuot, Delphine S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725867/
https://ncbi.nlm.nih.gov/pubmed/33190561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16281
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares